WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
PHASE1
This phase I trial studies the side effects and the best dose of WEE1 inhib...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) - Improving Access to Alzheimer's Disease Diagnostics: A Pragmatic System Level Intervention
N/A
The BioMIND (Biomarkers for the Molecular Identification of Neurodegenerati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07422038
Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
N/A
This is an observational study aiming to screen biomarkers associated with ...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang
Start Date
2025-11-01
Trial ID
NCT07479758
Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery
NA
This study is to assess the benefits of goal-directed fluid management with...
Salivary Biomarkers for Non-small Cell Lung Cancer Detection
N/A
The investigators plan to recruit patients for a prospective study in patie...
Status
Unknown
Location
St. John Macomb-Oakland Hospital
Start Date
2014-12
Trial ID
NCT02294578
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
PHASE1
This phase I trial is studying the side effects and best dose of erlotinib ...